摘要
目的探讨思密达与培菲康联合治疗小儿急性腹泻的疗效。方法将100例小儿急性腹泻患儿随机分为治疗组和对照组,每组各50例,均给予口服思密达及对症治疗,治疗组加用培菲康,比较2组疗效。结果治疗组和对照组的总有效率,分别为94%和74%,平均止泻时间分别为(50.54±6.22)h和(98.16±14.92)h,差异有统计学意义(P<0.05)。结论思密达与培菲康联合治疗小儿急性腹泻疗效好,可以在临床中推广应用。
Objective To evaluate the curative effect of Smecta combined with Bifico for acute diarrhea in children. Methods One hundred cases with diarrhea received symptomatic supportive therapy were divided randomly into two groups （n = 50）. The treatment group was administered with Bifico and Smecta,and the control group with Smecta only. The curative effect of the two groups was compared. Results The total effective rate of the treatment group was 94% ,and of the control group was 74%. The mean recovery time of the two group was （ 50.54 ± 6.22 ） h and （ 98.16 ± 14.92 ） h respectively. There was a statistic difference （ P 〈 0. 05 ）. Conclusions Bifieo combined with Smeeta have good curative effect for infantile diarrhea. It is worthy to be popularized in clinic.
出处
《实用全科医学》
2007年第7期611-612,共2页
Applied Journal Of General Practice
